Gentiva Health Services (Nasdaq: GTIV) reported earnings on Aug. 8. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), Gentiva Health Services missed slightly on revenue and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue dropped and GAAP earnings per share improved significantly.

Gross margins improved, operating margins contracted, and net margins expanded.

Revenue details
Gentiva Health Services logged revenue of $427.7 million. The six analysts polled by S&P Capital IQ anticipated revenue of $436.2 million on the same basis. GAAP reported sales were 4.7% lower than the prior-year quarter's $448.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.35. The six earnings estimates compiled by S&P Capital IQ predicted $0.28 per share. GAAP EPS of $0.46 for Q2 were 171% higher than the prior-year quarter's $0.17 per share. (The prior-year quarter included $0.02 per share in earnings from discontinued operations.)

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 47.9%, 10 basis points better than the prior-year quarter. Operating margin was 9.6%, 20 basis points worse than the prior-year quarter. Net margin was 3.3%, 210 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $428.4 million. On the bottom line, the average EPS estimate is $0.28.

Next year's average estimate for revenue is $1.73 billion. The average EPS estimate is $1.23.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 293 members out of 310 rating the stock outperform, and 17 members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 87 give Gentiva Health Services a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $7.90.